DAFTAR PUSTAKA

1. WHO. HIV/AIDS. Available from : http://www.who.int/topics/hiv_ aids

/en/.

2. Centers for Disease Control and Prevention. Basic information about HIV

and AIDS. Available from: http://www.cdc.gov/hiv/topics/basic/.

3. Sofro MAU, Anurogo D. Kewaspadaan universal dalam menangani

penderita HIV/AIDS. In: 5 Menit Memahami 55 Problematika Kesehatan.

Editor: Wee D. Jogjakarta: D-Medika; 2013. p. 143-8.

4. Komisi Penanggulangan AIDS Nasional. Situasi HIV dan AIDS di

Indonesia. Jakarta; 2009.

5. UNAIDS. UNAIDS World AIDS Day Report 2011. Geneva (Swizerland);

2011.

6. Direktorat Jendral PP dan PL Kementrian Kesehatan RI. Laporan Situasi

Perkembangan HIV/AIDS di Indonesia s.d. 30 Juni 2012. Jakarta

(Indonesia); 2012.

7. Fang CT, Chang YY, Hsu HM, Twu SJ, Chen KT, Lin CC et al. Life

expectancy of patients with newly diagnosed HIV infection in the era of

highly active antiretroviral therapy. Q J Med. 2007;100:97-105.

8. Mills EJ, Bakanda C, Birungi J, Mwesigwa R, Chan K, Ford N et al. Life

expectancy of persons receiving combination antiretroviral therapy in low-

income countries. Annals of Internal Medicine. 2011; 155(4):209-15.

66
 67

9. Miller LG, Hayz RD. Measuring adherence to antiretroviral medications in

clinical trial. HIV Clin Trial. 2000; 1(1):36-46. (Abstrak).

10. Nasronudin. Pengembangan pengetahuan penyakit infeksi HIV dan AIDS.

In: HIV dan AIDS Pendekatan Biologi Molekuler, Klinis, dan Sosial.

Editor: Barakbah J, Soewandojo E, Suharto, Hadi U, Astuti WD.

Surabaya: Airlangga University Press; 2007. p. 279-303.

11. Astari L, Sawitri, Safitri YE, Hinda D. Viral load pada infeksi HIV.

Berkala Ilmu Kesehatan Kulit dan Kelamin. 2009; 21(1):31-8.

12. Farzadegan H, Hoover DR, Astemborski J, Lyles CM, Margolick JB,

Markham RB et al. Sex differences in HIV-1 viral load and progression to

AIDS. The Lancet.1998; 352(9139):1510-4.

13. Petrushkin H. Psychiatric disorders in HIV-positive individual in urban

Uganda. The Psychiatrist. 2005; 29:455-8.

14. Pence BW. The impact of mental health and traumatic life experiences on

antiretroviral treatment outcomes for people living with HIV/AIDS.

Journal of Antimicrobial Chemotherapy. 2009; 63(4):636-40.

15. Marubenny S. Perbedaan respon sosial penderita HIV-AIDS yang

mendapat dukungan keluarga dan tidak mendapat dukungan keluarga di

Balai Kesehatan Paru (BKPM) Semarang. Semarang (Indonesia):

Universitas Muhamadiyah; 2011. (Tesis).

16. S Vella, M Guiliano, M Floridia, A Chiesi , C Tomino, A Seeber et al.

Effect of sex, age, and transmission cathegory on the progression to AIDS

 68

and survival of Zidovudin-treated symptomatic patients. AIDS.1995;

9(1):51-6. (Abstrak).

17. Brooks, GF, Butell JS, Morse SA. “AIDS dan Lentivirus”. In: Buku Ajar

Mikrobiologi Kedokteran Jawetz, Melnick, & Adelberg Edisi 23. Editor:

Elferia RN, Ramadhani D, Karolina S, Indriyani F, Rianti SSP, Yulia P.

Jakarta: Penerbit Buku Kedokteran EGC. 2007; p. 617.

18. Komisi Penanggulangan AIDS Nasional. Info HIV dan AIDS. Jakarta;

2010.

19. Dinas Kesehatan Kota Semarang. Profil kesehatan kota Semarang.

Semarang (Indonesia): Dinas Kesehatan Kota Semarang. 2011; p. 50-1.

20. Djoerban Z, Djauzi S. “HIV/AIDS di Indonesia”. In: Buku Ajar Ilmu

Penyakit Dalam Edisi V. Editor: Sudoyo AW, Setiyohadi B, Alwi I,

Simadibrata M, Setiati S. Jakarta: Pusat Penerbitan IPD FKUI. 2009; p.

2861.

21. Siregar, F. A. Pengenalan dan pencegahan AIDS. Sumut (Indonesia):

Universitas Sumatera Utara; 2004. (Disertasi).

22. WHO. WHO case definitions of HIV for surveilance and revised clinical

stagging and immunological classification of HIV related disease in adult

and children. Geneva (Switzerland); 2007.

23. Nasronudin. HIV/AIDS. In: Penyakit infeksi di Indonesia solusi kini dan

mendatang. Editor: Hadi U, Vitanata, Erwin AT, Suharto, Bramantono,

Soewandojo E. Surabaya: Airlangga University Press. 2007; p. 15 – 7.

 69

24. Dewi RS. Angka harapan hidup sebagai indikator derajat kesehatan di

Indonesia. Surabaya (Indonesia): Universitas Airlangga; 2010. (Tesis).

25. Adetunji J. Trends in under-5 mortality rates and the HIV/AIDS epidemic.

Bulletin World Health Organitation; 2000.

26. KM Harisson. Life Expectancy Still Shorter for People With HIV; 2009.

27. JW Mellors, A Munoz, JV Giorgi, JB Margolick, CJ Tassoni, P Gupta et

al. Plasma viral load and CD4+ lymphocytes as prognostic markers of

HIV-1 infection. Ann Intern Med. 1997; 126(12):946-54.

28. R Baker. HIV viral load supercedes CD4 count as best marker for

predicting risk of AIDS and death. BETA.1996; 9-11. (Abstrak).

29. Wainberg MA, Zaharatos GJ, Brenner BG. Development of Antiretroviral

Drug Resistance. N Engl J Med. 2011; 365:637-46.

30. Horn T. HIV drug resistence and resistance testing; 2001.

31. Sterling TR, Vlahov D, Astemborski J, Hoover DR, Margolick JB, Quinn

TC. Initial Plasma HIV-1 RNA Level and Progression To AIDS in

Women And Men. N Engl J Med. 2001; 344(10):720-5.

32. AG Babiker, T Peto, K Porter, AS Walker, JH Darbishire. Age as a

determinant of survival in HIV infection. J Clin Epidemiol. 2001;

54(12):16-21. (Abstrak).

33. Nguyen N, Holodny M. HIV infection in ederly. Clin Interv Aging. 2008;

3(3): 453-72.
 70

34. Chen NE, Gallant JE, Page KR. A systematic review of HIV/AIDS

survival and delayed diagnosis among hispanics in the United States.

Journal of Immigrant and Minority Health. 2012; 14(1):65-81. (Abstrak).

35. Losina E, Schackman BR, Sadownik SN, Gebo KA, Walensky RP, Chiosi

JJ, Weinstein MC et al. Racial and gender disparities in life expectancy

losses among HIV-infected persons in the United States. Clin Infect Dis.

2009; 49(10):1570-8.

36. Swindells S, Cobos DG, Lee N, Lien EA, Fitzgerald AP, Pauls JS et al.

Racial/ethnic differences in CD4 T cell count and viral load at presentation

for medical care and in follow-up after HIV-1 infection. Journal of The

International AIDS Society. 2002; 16(13):1832–4.

37. Aji HS. Kepatuhan HIV dan AIDS terhadap terapi antiretroviral di RSUP

Dr. Kariadi. Jurnal Promosi Kesehatan Indonesia. 2010; 5(1):58-67.

38. KemenKes RI. Pedoman Nasional Terapi Antiretroviral 2011. Departemen

Kesehatan Republik Indonesia Direktorat Jendral Pengendalian Penyakit

dan Penyehatan Lingkungan. Jakarta: 2011; p. 14,46.

39. Laniece, Ciss M, Desclaux A, Diop K, Mbokj F, Nydiaye B et al.

Adhrence HAART and its principal determinant in a cohort of Senegaleze

adult. Journal of The International AIDS Society. 2003; 17:103-8.

40. Mariam S, Radji M, Budi E. Perbandingan respon imunologi empat

kombinasi antiretroviral berdasarkan kenaikan jumlah CD4. Jurnal

Farmasi Indonesia. 2011; 5(3):159-65.

 71

41. Hogg R, V Lima, JA Sterne, S Grabar, M Battegay, M Bonarek et al. Life

expectancy of individuals on combination antiretroviral therapy in high-

income countries. Lancet. 2008; 372(9635):293-9.

42. May M, Gompels M, Delpech V, Porter K, Post F, Johnson M et al.

Impact of late diagnoses and treatment on life expectancy in people with

HIV-1. BMJ. 2011; 23:1743-53.

43. Riyarto S, Wijayanti Y, Indriani C, Wilasto N, Lazuardi E, Mahendradatta

Y. Faktor-faktor yang mempengaruhi keterlambatan diagnosis HIV dan

AIDS di Yogyakarta, Solo, dan Semarang. Yogyakarta: Universitas

GajahMada; 2010.

44. Malamba SS, Morgan D, Clayton T, Mayanja B, Okongo M, Whithword J.

The prognostic value of the World Health Organisation staging system for

HIV infection and disease in rural Uganda. Journal of The International

AIDS Society. 1999; 13(18):2555-62.

45. WHO. Nutrient requirements for people living with HIV/AIDS : report of

a technical consultation. Geneva; 2003.

46. Jafar N. Malnutrisi pada HIV dan AIDS. Makassar (Indonesia):

Universitas Hasanuddin; 2004. (Disertasi).

47. Van der Sande MA, Van der Loeff MF, Aveika AA, Sabally S, Togun T,

Sarge-Njie R et al. Body mass index at time of HIV diagnosis: a strong

and independent predictor of survival. Journal of Acquired Immune

Deficiency Syndromes. 2004; 37(2):1288-94.

 72

48. Castelman T, E Seumo-Fosso, B Cogill. Food and Nutrition Implications

of Antiretroviral Therapy in Resource Limited Settings. Food and

Nutrition Technical Assistance. 2004; 3(1):154-7. (Abstrak).

49. Goldwasser P, Feldman JG. Association of serum albumin and mortality

risk. J Clin Epidemiol. 2000; 50:693-703.

50. Gibbs J, Cull W, Henderson W, Daley J, Hur K, Khuri SF. Preoperative

serum albumin level as a predictor of operative mortality and morbidity:

Results from the national VA surgical risk study. Arch Surg. 2000; 134(1):

36 -42.

51. Volberding PA, Levine AM, Dieterich D, Mildvan D, Mitsuyasu R, Saag

M. Anemia in HIV infection. Clin Infect Dis. 2004; 38(10):1454–63.

52. O'Brien M, Kupka R, Msamanga, Gernard I, Saathoff, Elmar et al. Anemia

is an independent predictor of mortality and immunologic progression of

disease among women with HIV in Tanzania. Journal of Acquired

Immune Deficiency Syndromes. 2005; 40(2):219-25.

53. Gunung IK, Sumantera IGM. Perawatan dan dukungan. In: Buku

Pegangan Konselor HIV/AIDS. Editor: Sawitri AAS, Wirawan DN.

Australia: Centre for International Health. 2003; p. 128-30.

54. Macfarlane Burnet Institute for Medical Research and Public Health

LimitedMassiah E, Roach TC, Jacobs C, John AM, Inniss V, Walcott J.

Stigma, discrimination, and HIV/AIDS knowledge among physician in

Barbados. SciELO Public Health. 2004; 16(6):395-401.

 73

55. Centers for Disease Control and Prevention. Male circumcision. Atlanta

(USA); 2012.

56. WHO. Male circumcision for HIV prevention. Geneva (Switzerland);

2012.

57. Laksana ASD, Lestari DWD. Faktor–faktor risiko penularan HIV/AIDS

pada laki-laki dengan orientasi seks heteroseksual dan homoseksual di

Purwokerto. Mandala of Health. 2010; 4(2):113-23.

58. Mills EJ, Bakanda C, Birungi J, Mwesigwa R, Chan K, Ford N et al.

Mortality by baseline CD4 cell count among HIV patients initiating

antiretroviral therapy in Uganda. AIDS; 2011; 25(6):851–5.

59. Direktorat Jendral PP dan PL Kementrian Kesehatan RI. Laporan Situasi

Perkembangan HIV/AIDS di Indonesia s.d. 31 Maret 2013. Jakarta

(Indonesia); 2013.

60. Santoro LG, Harrison LH, Moulton LH, Lima LAA, de Pinho AMF, Hofer

C et al. Gender and survival after AIDS in Rio de Janeiro, Brazil. Journal

of Acquired Immune Deficiency Syndromes. 1998; 19(4):403-7.

61. Babiker A, Darby S, De Angelis D, Kwart D, Porter K, Beral V et al. Time

from HIV-1 seroconversion to AIDS and death before widespread use of

highly-active antiretroviral therapy. Lancet. 1999; 355(9210):1131-7.

(Abstrak).

62. French N, Mujugira A, Nakiyingi J, Mulder D, Janof EN, Gilks CF.

Immunologic and clinical stages in HIV-1 infected Ugandan adults are

comparable and provide no evidence of rapid progression but poor

 74

survival with advance disease. Journal of Acquired Immune Deficiency

Syndromes. 1999; 22(5):509-16.

63. Ehmann WC, Eyster ME, Wilson SE, Andes GA, Goedert JJ. Relationship

of CD4 lymphocyte counts to survival in a cohort of hemophiliacs infected

with HIV. Journal of Acquired Immune Deficiency Syndromes. 1994;

7(10):1095-8.